Collard Craig A

Heron Therapeutics, Inc. ยท Chief Executive Officer

Collard Craig A is listed in public filings as director, officer: Chief Executive Officer. This Collard Craig A insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Heron Therapeutics, Inc. (HRTX). Investors use Collard Craig A's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Heron Therapeutics, Inc.HRTX--382.7k sharesGrant / ExerciseApr 30, 2026Disclosure amount unavailable34.8k shares----
Heron Therapeutics, Inc.HRTX--750.3k sharesGrant / ExerciseApr 30, 2026Disclosure amount unavailable50k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Heron Therapeutics, Inc.HRTX--96.8k sharesGrant / ExerciseApr 19, 2026Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--62.5k sharesGrant / ExerciseApr 3, 2026Disclosure amount unavailable62.5k shares----
Heron Therapeutics, Inc.HRTX--417.5k sharesGrant / ExerciseJan 31, 2026Disclosure amount unavailable34.8k shares----
Heron Therapeutics, Inc.HRTX--800.3k sharesGrant / ExerciseJan 30, 2026Disclosure amount unavailable800.3k shares----
Heron Therapeutics, Inc.HRTX--800.3k sharesGrant / ExerciseJan 30, 2026Disclosure amount unavailable800.3k shares----
Heron Therapeutics, Inc.HRTX--110.4k sharesGrant / ExerciseJan 19, 2026Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--452.3k sharesGrant / ExerciseOct 31, 2025Disclosure amount unavailable34.8k shares----
Heron Therapeutics, Inc.HRTX--124.2k sharesGrant / ExerciseOct 19, 2025Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--474.5k sharesGrant / ExerciseJul 31, 2025Disclosure amount unavailable34.8k shares----
Heron Therapeutics, Inc.HRTX--138k sharesGrant / ExerciseJul 19, 2025Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--426k sharesGrant / ExerciseApr 30, 2025Disclosure amount unavailable34.8k shares----
Heron Therapeutics, Inc.HRTX--151.8k sharesGrant / ExerciseApr 19, 2025Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--125k sharesGrant / ExerciseApr 3, 2025Disclosure amount unavailable62.5k shares----
Heron Therapeutics, Inc.HRTX$1.9M1.1M sharesGrant / ExerciseJan 31, 2025$1.9M1.1M shares$1.70--
Heron Therapeutics, Inc.HRTX--556.6k sharesGrant / ExerciseJan 31, 2025Disclosure amount unavailable556.6k shares----
Heron Therapeutics, Inc.HRTX--165.6k sharesGrant / ExerciseJan 19, 2025Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--179.4k sharesGrant / ExerciseOct 19, 2024Disclosure amount unavailable13.8k shares----
Heron Therapeutics, Inc.HRTX--193.2k sharesGrant / ExerciseJul 19, 2024Disclosure amount unavailable13.8k shares----